"Mouth Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the MOUTH.
Descriptor ID |
D009062
|
MeSH Number(s) |
C04.588.443.591 C07.465.565
|
Concept/Terms |
Mouth Neoplasms- Mouth Neoplasms
- Mouth Neoplasm
- Neoplasm, Mouth
- Neoplasms, Oral
- Neoplasm, Oral
- Oral Neoplasm
- Oral Neoplasms
- Neoplasms, Mouth
Cancer of Mouth- Cancer of Mouth
- Mouth Cancers
- Mouth Cancer
- Cancer, Mouth
- Cancers, Mouth
- Oral Cancer
- Cancer, Oral
- Cancers, Oral
- Oral Cancers
- Cancer of the Mouth
|
Below are MeSH descriptors whose meaning is more general than "Mouth Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Mouth Neoplasms".
This graph shows the total number of publications written about "Mouth Neoplasms" by people in this website by year, and whether "Mouth Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 3 | 5 |
1995 | 5 | 3 | 8 |
1996 | 1 | 2 | 3 |
1997 | 5 | 0 | 5 |
1998 | 7 | 0 | 7 |
1999 | 8 | 2 | 10 |
2000 | 10 | 1 | 11 |
2001 | 13 | 0 | 13 |
2002 | 9 | 2 | 11 |
2003 | 9 | 0 | 9 |
2004 | 13 | 2 | 15 |
2005 | 5 | 2 | 7 |
2006 | 14 | 3 | 17 |
2007 | 9 | 2 | 11 |
2008 | 28 | 2 | 30 |
2009 | 12 | 4 | 16 |
2010 | 15 | 0 | 15 |
2011 | 10 | 3 | 13 |
2012 | 12 | 1 | 13 |
2013 | 23 | 3 | 26 |
2014 | 4 | 4 | 8 |
2015 | 8 | 1 | 9 |
2016 | 10 | 1 | 11 |
2017 | 15 | 1 | 16 |
2018 | 10 | 0 | 10 |
2019 | 9 | 1 | 10 |
2020 | 9 | 4 | 13 |
2021 | 9 | 0 | 9 |
2022 | 9 | 0 | 9 |
2023 | 12 | 0 | 12 |
2024 | 7 | 0 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mouth Neoplasms" by people in Profiles.
-
Reconstructing oral cavity tumor evolution through brush biopsy. Sci Rep. 2024 09 30; 14(1):22591.
-
Sentinel Node Biopsy in Oral Cancer-Indications, Analysis, and Outcomes. JAMA Otolaryngol Head Neck Surg. 2024 Jul 01; 150(7):634.
-
Oral Pre-malignancy: An Update on Novel Therapeutic Approaches. Curr Oncol Rep. 2024 Sep; 26(9):1047-1056.
-
Novel non-invasive molecular signatures for oral cavity cancer, by whole transcriptome and small non-coding RNA sequencing analyses: Predicted association with PI3K/AKT/mTOR pathway. Cancer Med. 2024 Jun; 13(11):e7309.
-
Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral cancer. Oral Oncol. 2024 Jun; 153:106729.
-
DDX3 regulates cancer immune surveillance via 3' UTR-mediated cell-surface expression of PD-L1. Cell Rep. 2024 Mar 26; 43(3):113937.
-
Neoadjuvant chemotherapy for advanced oral cavity cancer. CA Cancer J Clin. 2024 May-Jun; 74(3):213-223.
-
Gastrointestinal tract pathology of the owl monkey (Aotus spp.). Vet Pathol. 2024 03; 61(2):316-323.
-
TP53 gain-of-function mutation modulates the immunosuppressive microenvironment in non-HPV-associated oral squamous cell carcinoma. J Immunother Cancer. 2023 08; 11(8).
-
Margins in Stage I and II Oral Cavity Squamous Cell Carcinoma: A Review From the American Head and Neck Society. JAMA Otolaryngol Head Neck Surg. 2023 07 01; 149(7):636-642.